PSA detectable 18 mos after prostatectomy

Posted by Ksusan @kscharmer, Jan 10 3:10pm

My husband had a prostatectomy in June 2022. Postsurgery PSA tests were all undetectable < .10 until January 8, 2024. The PSA result was .14
Does this mean his cancer has returned? Can PSA fluctuate?
We spoke to a friend who had a prostatectomy 9 yrs ago and had two detectable PSA >.10 tests then returned to undetectable. Is this typical?

Interested in more discussions like this? Go to the Prostate Cancer Support Group.

@kujhawk1978

Been there, done that...

a .14 sounds like an USPSA test.

With USPSA, measuring to two decimals, there is not, at least that I have found, a commonly agreed upon definition of BCR.

With the standard tests, to single decimal, the generally agreed upon definition of BCR is two or more consecutive increases where PSA it .2, then .3, spaced several months apart. As others have said, use the same lab and generally try and follow the same routine prior to the draw.

Going back to my high school math, if your husband's PSA was a single decimal one, rounding off would be to .1 (< .5, round down,,,)and likely you two would be saying to your medical team, "see you in...!"

As others have said, what you and your medical team look for are trends. A single data point with PSA shouldn't constitute clinical data sufficient for a treatment decision. Discuss with your medical team about when to have another PSA test, one, two, three months...whatever you decide, you'll have another decision when that comes:

If it increases again, what do you do? The urge will be to act and do something. But, then the question of imaging comes in, do you into image then or wait until it increases say to .5-1.0 where imaging such as Plarufy (not C11 Choline or Aximun!) statistically has a better chance of locating any recurrence. If you decide that, you may have more clinical data to make an informed decision on any treatment, likely doublet or triplet therapy.

Take some time to do your homework, read the NCCN guidelines, do a literature search on doublet or triplet therapy. That will inform you and may guide your discussion with your medical team.

This may also be the time to bring a radiologist and oncologist onboard if you have not already done so. If so, they should have a focus on treating prostate cancer!

I've attached my clinical history. As you can see, 15 months after a very successful surgery my urologist hesitated after looking at his screen and my PSA results. You can also see that when my urologist switch to USPSA test, it went from undetectable to .36, then went down, later it went up, then back down. Finally in late 2022 and early 2023, it went up and up...That's when we decided to treat again, not the previous two ups and downs.

You don't give his pathology report, GS, ECE, SVN % of prostate involvement, Margins...so the forum doesn't know his risk category. Certainly if he has BCR at 18 months, that is a high risk factor.

It's frightening, I know. I think the good news is the revolution in treatment and management of advanced prostate cancer, and more is in the research pipeline. That means a dizzying array of treatment choices though!

Kevin

Jump to this post

GS 3+4=7 (lesst han 5% grade 4)
T2
ECE neg
SV neg
Margins neg

REPLY
@kscharmer

GS 3+4=7 (lesst han 5% grade 4)
T2
ECE neg
SV neg
Margins neg

Jump to this post

Thanx, that's a "good" pathology report.

Like mine, only my GS was 4+4...

the 3+4 puts him in the zone of Grade Groups 2, intermediate risk.

If he does have a BCR based on additional PSA testing, the less than three years to BCR, that may move into the the high risk group.

Kevin

REPLY
@kujhawk1978

Thanx, that's a "good" pathology report.

Like mine, only my GS was 4+4...

the 3+4 puts him in the zone of Grade Groups 2, intermediate risk.

If he does have a BCR based on additional PSA testing, the less than three years to BCR, that may move into the the high risk group.

Kevin

Jump to this post

Isn’t BCR defined as >.20? So he’s not there yet?
Median time to BCR ranges from 20 to 38 months (15, 19). Although BCR occurs more often in first 3 years from RP, longer follow-ups are required whereas a considerable number of patients may recur even after 15 years (20, 21).

Biochemical recurrence after radical prostatectomy - NCBI

REPLY
@kujhawk1978

Thanx, that's a "good" pathology report.

Like mine, only my GS was 4+4...

the 3+4 puts him in the zone of Grade Groups 2, intermediate risk.

If he does have a BCR based on additional PSA testing, the less than three years to BCR, that may move into the the high risk group.

Kevin

Jump to this post

Is it possible for psa to stabilize or go down?

REPLY
@kscharmer

Isn’t BCR defined as >.20? So he’s not there yet?
Median time to BCR ranges from 20 to 38 months (15, 19). Although BCR occurs more often in first 3 years from RP, longer follow-ups are required whereas a considerable number of patients may recur even after 15 years (20, 21).

Biochemical recurrence after radical prostatectomy - NCBI

Jump to this post

BCR is defined as PSA >.2 on two or more tests, typically three months apart.

That is with a standard PSA test, it appears his educates us using an ultra sensitive test, there are divergent opinions about BCR for USPSA test results

REPLY
@kscharmer

Is it possible for psa to stabilize or go down?

Jump to this post

Yes, see the chart I attached.

REPLY
@kujhawk1978

Been there, done that...

a .14 sounds like an USPSA test.

With USPSA, measuring to two decimals, there is not, at least that I have found, a commonly agreed upon definition of BCR.

With the standard tests, to single decimal, the generally agreed upon definition of BCR is two or more consecutive increases where PSA it .2, then .3, spaced several months apart. As others have said, use the same lab and generally try and follow the same routine prior to the draw.

Going back to my high school math, if your husband's PSA was a single decimal one, rounding off would be to .1 (< .5, round down,,,)and likely you two would be saying to your medical team, "see you in...!"

As others have said, what you and your medical team look for are trends. A single data point with PSA shouldn't constitute clinical data sufficient for a treatment decision. Discuss with your medical team about when to have another PSA test, one, two, three months...whatever you decide, you'll have another decision when that comes:

If it increases again, what do you do? The urge will be to act and do something. But, then the question of imaging comes in, do you into image then or wait until it increases say to .5-1.0 where imaging such as Plarufy (not C11 Choline or Aximun!) statistically has a better chance of locating any recurrence. If you decide that, you may have more clinical data to make an informed decision on any treatment, likely doublet or triplet therapy.

Take some time to do your homework, read the NCCN guidelines, do a literature search on doublet or triplet therapy. That will inform you and may guide your discussion with your medical team.

This may also be the time to bring a radiologist and oncologist onboard if you have not already done so. If so, they should have a focus on treating prostate cancer!

I've attached my clinical history. As you can see, 15 months after a very successful surgery my urologist hesitated after looking at his screen and my PSA results. You can also see that when my urologist switch to USPSA test, it went from undetectable to .36, then went down, later it went up, then back down. Finally in late 2022 and early 2023, it went up and up...That's when we decided to treat again, not the previous two ups and downs.

You don't give his pathology report, GS, ECE, SVN % of prostate involvement, Margins...so the forum doesn't know his risk category. Certainly if he has BCR at 18 months, that is a high risk factor.

It's frightening, I know. I think the good news is the revolution in treatment and management of advanced prostate cancer, and more is in the research pipeline. That means a dizzying array of treatment choices though!

Kevin

Jump to this post

Thanks for sharing your chart Kevin, looks like you are doing well 9 years out

REPLY

I also had my RP in June 2022 and I am in a clinical trial for Erleada. In the trial the men who had surgery and then ADT could expect an increase in PSA in about 17 months and the men that got the ADT plus Erleada could expect a PSA rise in about 41 months. The trial was for high risk, high Gleason CR PC. Hence, the 17 months from RP might not be unusual.

REPLY

Hello Group:

I had Robotic Prostate Surgery Aug. 2, 2022. Had 5 PSA tests since surgery. Here are the levels 0.06; 0.11; 0.12; 0.13; 0.13. Met with Radiation Oncologist last week after last PSA test and he recommended that I have another PSA test in April. He said he follows the American Guidlines that which indicates radiation from 0.18 to 0.23. Has anyone experienced rising PSA post surgery and if so, what were the next steps?

REPLY
@mmuise1

Hello Group:

I had Robotic Prostate Surgery Aug. 2, 2022. Had 5 PSA tests since surgery. Here are the levels 0.06; 0.11; 0.12; 0.13; 0.13. Met with Radiation Oncologist last week after last PSA test and he recommended that I have another PSA test in April. He said he follows the American Guidlines that which indicates radiation from 0.18 to 0.23. Has anyone experienced rising PSA post surgery and if so, what were the next steps?

Jump to this post

I recommend considering these inputs. They help to explain potential next steps, when, and why. At your level of PSA, the challenge is knowing where to radiate.
"What to ask when PSA is rising after the initial treatment:"
PCF - https://www.pcf.org/about-prostate-cancer/diagnosis-staging-prostate-cancer/psa-rising/what-to-ask-when-your-psa-is-rising-after-initial-treatment/
"Rising PSA after initial treatment. PCRI" - https://www.youtube.com/watch?v=X_FtOBTIOj0

REPLY
Please sign in or register to post a reply.